Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
Bristol-Myers Squibb Company (NYSE:BMY) discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products worldwide.
It will report its Q4 2024 earnings on Feb. 6, 2025. Wall Street analysts expect the company to post an EPS of $1.48, down from $1.70 in the year-ago period. According to data from Benzinga Pro, quarterly revenue is expected to be $11.54 billion, up from $11.48 billion in the year-ago period.
The 52-week range of Bristol-Myers Squibb’s stock price was $39.35 to $61.08.
Bristol-Myers Squibb’s dividend yield is 4.38%. During the last 12 months, it paid $2.48 per share in dividends.
Don't Miss:
-
Unlock the hidden potential of commercial real estate — This platform allows individuals to invest in commercial real estate offering a 12% target yield with a bonus 1% return boost today!
-
This Jeff Bezos-backed startup will allow you to become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.
The Latest On Bristol-Myers Squibb
On Oct. 31, the company announced its Q3 2024 earnings, posting revenues of $11.89 billion, beating the consensus of $11.28 billion, as reported by Benzinga.
Growth Portfolio worldwide revenues increased to $5.81 billion compared to $4.95 billion a year ago, representing growth of 18% on a reported basis or 20% when adjusted for foreign exchange impacts. Higher demand for Reblozyl, Breyanzi, Camzyos and Opdualag primarily drove growth portfolio revenues.
Bristol Myers Squibb forecasts 2024 adjusted EPS of $0.75-$0.95 versus prior guidance of $0.60-$0.90 and consensus of $0.71. For 2024, the U.S. drugmaker expects 2024 revenue growth of around 6% compared to the upper end of the previously provided low single-digit range.
Check out this article by Benzinga, which decodes Bristol-Myers Squibb’s options activity.
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — you can become an investor for $0.80 per share today.
How Can You Earn $100 Per Month As A Bristol-Myers Squibb Investor?
If you want to make $100 per month – $1,200 annually – from Bristol-Myers Squibb dividends, your investment value needs to be approximately $27,397, which is around 484 shares at $56.57 each.
Understanding the dividend yield calculations: When estimating, you need two key variables – the desired annual income ($1,200) and the dividend yield (4.38% in this case). So, $1,200 / 0.0438 = $27,397 to generate an income of $100 per month.